ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025

Core Insights - ClearPoint Neuro, Inc. will participate in multiple global healthcare conferences in the fourth quarter of 2025, showcasing its commitment to engaging with investors and stakeholders in the healthcare sector [1][2]. Conference Participation - The company is scheduled to present at the following conferences: - 2025 UBS Global Healthcare Conference on November 10, 2025 [2] - 2025 Stifel Healthcare Conference on November 13, 2025 [2] - 37th Annual Piper Sandler Healthcare Conference on December 3, 2025 [2] - ClearPoint Neuro management will be available for in-person investor meetings at these events [2]. Company Overview - ClearPoint Neuro specializes in device, cell, and gene therapy-enabling technologies, providing precise navigation solutions for the brain and spine [3]. - The flagship product, the ClearPoint Neuro Navigation System, has received FDA clearance and is CE-marked, indicating its regulatory compliance and market readiness [3]. - The company collaborates with healthcare and research centers across North America, Europe, Asia, and South America, and partners with leading pharmaceutical and biotech firms [3]. - Thousands of procedures have been supported by the company's clinical specialist team, highlighting its operational experience and market presence [3].